Abstract 5749: Determination of the mTOR inhibitor temsirolimus and its active metabolite sirolimus in human blood, plasma, cerebrospinal fluid, and brain tumor tissue using a validated LC-MS/MS assay
Authors: Gerold S. Kaplan, Tigran Margaryan, Nader Sanai, Artak Tovmasyan
Published: 2025-04-21
DOI:
10.1158/1538-7445.am2025-5749
Source:
Full article
Abstract
Abstract